Click on your section below to continue. Medicines are listed according to the categories of the BNF. If the medication you are looking for is not listed, there is currently no shared care available. AMBER with SHARED CARE drugs requires significant monitoring and must be designated as such by the BSW APC to be eligible. GPs are advised not to take charge of prescribing these medicines unless they have been properly informed in writing (by letter or secure email) of their responsibilities in terms of monitoring, side effects and interactions and are happy to take over the prescription. A copy of the locally approved SCA must be attached to the application. General practitioners should respond to the request as soon as possible if they are unable to support joint care (in writing or by secure email) and then arrange for the transfer of care as needed. This ensures absolute clarity on who takes care of the prescription and the associated monitoring tasks. Sharing care requires communication between the specialist, the family doctor and the patient. The intention to share care is usually explained to the patient by the prescribing physician who initiates the treatment. It is important that patients are consulted about the treatment and that they agree. Patients should be followed regularly in secondary care, where it is expected that the patient`s overall response to treatment and the need for further treatment will be monitored. They are individual for a particular drug, describe who is responsible for what aspect of care and when early referral to specialized services is needed.

They allow a transparent transfer of responsibility for the prescription of specialized services to general medicine. Shared Care Guidelines are local guidelines that allow primary care physicians to manage the prescribing and monitoring of medications and treatments in primary care in consultation with the initiating specialist. If you receive a request for a prescription if there is no shared care policy that you consider inappropriate, please complete an inappropriate request form. If a specialist considers a patient`s condition to be stable or predictable, he or she may seek the consent of the general practitioner in question (and the patient) to share his or her care. When proposing joint care arrangements, a specialist should provide advice on which medications to prescribe, what monitoring should take place in primary care, how often medications should be reviewed, and what to do if difficulties arise. Joint care requires communication between the specialist, family doctor and patient (and/or caregiver). The intention to share care should be explained to the patient by the attending physician. It is important that patients are consulted about the treatment and accept it. Patients receiving the given drug should be followed regularly, which gives the opportunity to discuss drug treatment. It should be noted that while a joint care agreement has been approved by the Somerset Prescribing Forum, there is a condition for the transition from specialized care to primary care based on that: ACS describes how the responsibilities for managing the prescription of a drug can be shared between the specialist and a family doctor. Family physicians are invited to participate.

If they are not able to perform these tasks, they are not obliged to do so. In such a case, the patient`s full clinical responsibility for this diagnosed condition remains with the specialist. Prescribing physicians are reminded that the physician prescribing the drug legally assumes clinical responsibility for the drug and the consequences of its use. A circular from the Ministry of Health first set out the principles that apply to joint care. This was EL91 (127) and can be viewed below: AMBER with SHARED CARE medicines requires significant monitoring and must be named as such by the East Lancashire Medicines and Therapies Committee to be eligible. GPs are advised not to prescribe these medicines unless they have been properly informed in writing of their responsibilities in terms of monitoring, side effects and interactions and are prepared to take responsibility for the prescription. A copy of the locally approved joint care document (if available) must be attached to this letter outlining these responsibilities. General practitioners should then inform secondary care by letter as soon as possible of their intentions, and then arrange for the transfer of care if necessary. . This ensures that there is absolute clarity about who is taking care of the prescription and what monitoring tasks are associated with it.

It was agreed by the Drug Optimization Committee that if the GP refuses to enter into a joint care agreement for a medicine deemed appropriate for joint care by NICE, the clinician must complete the pro forma for ESCA, which has been rejected by GPs, so that the trust can adequately burden the CCG. The CPA strives to check and adjust the condition of traffic lights (TLS) and SCAs in BSW. If there are differences between TLS and ACS, clinicians should refer to the agreement for their location. Shared care arrangements are a specific approach to transparent prescribing and monitoring of medications that allows patients to receive integrated and convenient care. Shared care is a special form of transfer of clinical responsibility from a hospital or specialist department to general practice, where the prescription by the general practitioner or other general practitioner is supported by an agreement on joint care. .